Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II-Reference-Cited by-同舟云学术

Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II

Published:2021-10-16 Issue:6 Volume:20 Page:2845
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Safaryan A. S.¹^ORCID,Nebieridze D. V.¹^ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

Abstract

The second part of the review considers different classes of drugs affecting blood pressure in increased activity of the sympathetic nervous system. Additional possibilities are discussed on how to reduce the negative effect of sympathetic hyperactivity on cardiovascular system and improve the prognosis.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference65 articles.

1. Safaryan AS, Sargsyan VD. Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part I. Cardiovascular Therapy and Prevention. 2020;19(6):2693. (In Russ.) doi:10.15829/1728-8800-2020-2693.

2. Noll G, Wenzel RR, Schneider M, et al. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation. 1996;93(5):866-9. doi:10.1161/01.cir.93.5.866.

3. Saxena T, Azeema O, Saxena M. Pathophysiology of essential hypertension: an update. Expert Rev Cardiovasc Ther. 2018;16(12):879-87. doi:10.1080/14779072.2018.1540301.

4. Converse RJ, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327(27):1912-8. doi:10.1056/NEJM199212313272704.

5. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) doi:10.15829/1560-4071-2020-3-3786.